Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer (vol 12, pg 764, 2019)

被引：0
|
作者：
Zhou, Dabo [1 ,2 ,3 ,4 ]
Liu, Liping [1 ,2 ,3 ,4 ]
Liu, Jingyu [1 ,2 ,3 ,4 ]
Tang, Yu [1 ,2 ,3 ,4 ]
Xiao, Mengjia [1 ,2 ,3 ,4 ]
Wang, Yikai [5 ]
He, Qiongzhi [6 ]
Hu, Zhe-Yu [1 ,2 ,3 ,4 ]
Ouyang, Quchang [1 ,2 ,3 ,4 ]
机构：
[1] Cent South Univ, Hunan Canc Hosp, Changsha 410013, Peoples R China
[2] Cent South Univ, Affiliated Canc Hosp, Xiangya Med Sch, Changsha 410013, Peoples R China
[3] Canc Hosp, Dept Breast Canc Med Oncol, Changsha 410013, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Med Sch, Affiliated Canc Hosp, Dept Breast Canc Med Oncol, Changsha 410013, Peoples R China
[5] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
[6] Geneplus Beijing Inst, Beijing 102206, Peoples R China
来源：
TRANSLATIONAL ONCOLOGY | 2021年 / 14卷 / 12期
关键词：
D O I：
10.1016/j.tranon.2021.101226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chemotherapy modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
    Zhou, Dabo
    Ouyang, Quchang
    Liu, Liping
    Liu, Jingyu
    Tang, Yu
    Xiao, Mengjia
    Wan, Yikai
    He, Qiongzhi
    Hu, Zhe-Yu
    TRANSLATIONAL ONCOLOGY, 2019, 12 (05): : 764 - 774
  • [2] Chemotherapy or endocrine therapy for metastatic breast cancer?
    Wilcken, N
    Hornbuckle, J
    Ghersi, D
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S53 - S56
  • [3] Chemotherapy or Endocrine Therapy for Metastatic Breast Cancer?
    Nicholas Wilcken
    Joanne Hornbuckle
    Davina Ghersi
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 53 - 56
  • [4] Endocrine therapy and chemotherapy in luminal metastatic breast cancer.
    Bonotto, Marta
    Gerratana, Lorenzo
    De Angelis, Carmine
    Arpino, Grazia
    Iacono, Donatella
    Cinausero, Marika
    Fasola, Gianpiero
    Puglisi, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
    Stockler, M
    Wilcken, NRC
    Ghersi, D
    Simes, RJ
    CANCER TREATMENT REVIEWS, 2000, 26 (03) : 151 - 168
  • [6] Use of maintenance endocrine therapy after chemotherapy in metastatic breast cancer
    Sutherland, S.
    Miles, D.
    Makris, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : 216 - 222
  • [7] Perspectives of Postmenopausal Breast Cancer Survivors on Adjuvant Endocrine Therapy-Related Symptoms
    van Londen, G. J.
    Donovan, Heidi S.
    Beckjord, Ellen B.
    Cardy, Alexandra L.
    Bovbjerg, Dana H.
    Davidson, Nancy E.
    Morse, Jennifer Q.
    Switzer, Galen E.
    Verdonck-de Leeuw, Irma M.
    Dew, Mary Amanda
    ONCOLOGY NURSING FORUM, 2014, 41 (06) : 660 - 668
  • [8] Therapy-related Leukaemia Cutis after Adjuvant Chemotherapy in a Breast Cancer Patient
    Lee, Haur Yueh
    Ng, Heng Joo
    Wong, Pek Choo Adele
    Pang, Shiu Ming
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (06) : 649 - 650
  • [9] Emerging strategies to overcome resistance to endocrine therapy for breast cancer (vol 33, pg 791, 2014)
    Ziauddin, M. Firdos
    Hua, Dong
    Tang, Shou-Ching
    CANCER AND METASTASIS REVIEWS, 2014, 33 (04) : 1127 - 1127
  • [10] Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer
    Alluri, Prasanna G.
    Larios, Jose
    Malik, Rohit
    Rae, James
    Chiinaiyan, Arul M.
    CANCER RESEARCH, 2016, 76
12345